Ahmad S. Alotaibi

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Blinatumomab and ponatinib with central nervous system treatment intensification for adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukemia.

Blinatumomab and ponatinib with central nervous system treatment intensification for adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: April 16, 2026

Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study.

Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study.

Journal: Cytotherapy

Published: October 21, 2025

Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.

Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology

Published: August 28, 2025

Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East.

Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 05, 2025

Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east.

Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east.

Journal: Cytotherapy

Published: May 15, 2025

Marking over a century of Auer rods: An illustrated review of acute promyelocytic leukemia.

Marking over a century of Auer rods: An illustrated review of acute promyelocytic leukemia.

Journal: Hematology/oncology and stem cell therapy

Published: February 23, 2025

Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience.

Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience.

Journal: Bone marrow transplantation

Published: February 10, 2025

The road not taken: Exploring non-transplant options in De Novo philadelphia positive acute myeloid leukemia.

The road not taken: Exploring non-transplant options in De Novo philadelphia positive acute myeloid leukemia.

Journal: Leukemia research reports

Published: January 20, 2025

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council.

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council.

Journal: Cancers

Published: November 25, 2024

Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis.

Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis.

Journal: Journal of hematology

Published: April 16, 2024

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Journal: Annals of Saudi medicine

Published: April 14, 2024

Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.

Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.

Journal: Transplantation and cellular therapy

Published: November 22, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026